VALGANCICLOVIR
Generic: VALGANCICLOVIR
Micro Labs LimitedManufacturer
ORALRoute
VALGANCICLOVIR HYDROCHLORIDEActive Substance
2026-03-19Original Approval
VALGANCICLOVIR is FDA application ANDA218838, sponsored by MICRO LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2019-11-04
Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL (3.4 fl. oz.) bottle, Rx only, Manufactured for: ActaviPresence of foreign substance: Brown/black particles found during stability testing.
Class II2018-02-13
Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. PiscatawaTemperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were expos
Top Reported Reactions
1
OFF LABEL USE
2,397 reports
2
CYTOMEGALOVIRUS INFECTION
1,445 reports
3
DRUG INEFFECTIVE
1,428 reports
4
NEUTROPENIA
1,029 reports
5
LEUKOPENIA
795 reports
6
ACUTE KIDNEY INJURY
728 reports
7
CYTOMEGALOVIRUS VIRAEMIA
714 reports
8
PYREXIA
691 reports
9
DIARRHOEA
663 reports
10
DRUG RESISTANCE
654 reports